Cover image of the article: Comparing the Effects of Laughter Therapy and Cognitive Behavioral Therapy on Mental Health and Hopefulness in Pakistani Dialysis Patients

Image Credit:Jundishapur J Chronic Dis Care

Comparing the Effects of Laughter Therapy and Cognitive Behavioral Therapy on Mental Health and Hopefulness in Pakistani Dialysis Patients

Authors

Muhammad Azam1, Muhammad SabirMuhammad Sabir ORCID1, Waseem Abbas1, Zobia Akram1, Shima Sadat AghahosseiniShima Sadat Aghahosseini ORCID1,*
1Lahore School of Nursing, The University of Lahore, Lahore, Pakistan
*Corresponding Author: Lahore School of Nursing, The University of Lahore, Lahore, Pakistan. Email: shimaaghahosseini@yahoo.com

Jundishapur Journal of Chronic Disease Care:Vol. 15, issue 4; e171965
Published online:Sep 29, 2026
Article type:Research Article
Received:May 15, 2026
Accepted:Sep 27, 2026
How to Cite:Azam M, Sabir M, Abbas W, Akram Z, Aghahosseini SS. Comparing the Effects of Laughter Therapy and Cognitive Behavioral Therapy on Mental Health and Hopefulness in Pakistani Dialysis Patients. Jundishapur J Chronic Dis Care. 2026;15(4):e171965. doi: https://doi.org/10.5812/jjcdc-171965

Abstract

Background:

Chronic renal failure often requires dialysis as a life-sustaining treatment. However, dialysis is frequently associated with psychological complications, including stress, depression, and hopelessness.

Objectives:

This study aimed to compare the effects of laughter therapy and cognitive behavioral therapy on mental health and hopefulness in Pakistani patients undergoing dialysis.

Methods:

A total of 145 patients meeting the inclusion criteria were enrolled in a quasi-experimental study using convenience sampling at teaching hospitals in Lahore. Participants were allocated to three groups: laughter therapy (LT; n = 48), cognitive behavioral therapy (CBT; n = 48), and control (n = 49). The interventions comprised eight 1-hour sessions. Data were collected using a demographic questionnaire, the Symptom Checklist-90-Revised (SCL-90-R), and the Snyder Hope Scale (SHS) at baseline, immediately after the intervention, and at the 3-month follow-up. A total of 135 participants completed the post-intervention assessment, and 121 completed the 3-month follow-up and were included in the final complete-case analysis.

Results:

There were no statistically significant differences in baseline demographic characteristics among the three groups (P > 0.05). The mean ages in the LT, CBT, and control groups were 48.11 ± 13.56, 49.00 ± 13.14, and 48.30 ± 13.38 years, respectively. Significant time × group interactions were observed for psychological symptom severity (F = 12.714, P < 0.001, ηp2 = 0.300) and hopefulness (F = 8.563, P < 0.001, ηp2 = 0.224). Psychological symptom severity decreased from 1.82 ± 0.23 to 1.67 ± 0.49 in the LT group and from 1.84 ± 0.21 to 1.62 ± 0.48 in the CBT group, whereas hopefulness increased from 37.22 ± 2.53 to 42.82 ± 4.63 and from 39.84 ± 3.13 to 42.40 ± 5.36, respectively. The control group did not show comparable improvements. These effects were generally maintained at the 3-month follow-up.

Conclusions:

Laughter therapy and cognitive behavioral therapy may help reduce psychological symptom severity and improve hopefulness in patients undergoing dialysis. The favorable effects of both interventions were generally maintained at the 3-month follow-up, supporting their potential use as complementary psychological interventions in dialysis care.

1. Background

In recent decades, chronic diseases have been recognized as major challenges facing health systems worldwide. Lifestyle changes, rapid urbanization, and advances in science and technology have contributed to a decline in communicable diseases; however, the prevalence of noncommunicable diseases continues to rise (1). Renal failure is a major chronic condition, and its incidence is increasing because of population aging and the high prevalence of diabetes and hypertension (2).
Chronic renal failure (CRF) is defined as a progressive and irreversible decline in kidney function. In advanced stages, the kidneys can no longer sustain life (3). It is a major health care challenge and a significant contributor to reduced quality of life (4). The global prevalence of chronic kidney disease is estimated to be between 8% and 16% (5).
The burden of chronic kidney disease is also substantial in Pakistan. Studies estimate that its prevalence ranges from approximately 12% to 15% among adults, largely driven by increasing rates of diabetes and hypertension (6).
Among patients with CRF, dialysis is the most common treatment used to compensate for reduced kidney function (7). Dialysis aims to prolong survival, reduce complications, and improve quality of life (8). Globally, more than 2 million patients rely on dialysis for survival. In Pakistan, more than 20,000 patients are estimated to receive regular dialysis, although many others lack access to adequate treatment because of financial and health care system constraints (9).
Despite its benefits, dialysis substantially affects patients’ physical, psychological, social, and emotional well-being. Common complications include stress, depression, hopelessness, denial, and poor treatment adherence (10). These problems can lead to dependency, occupational and social limitations, and ultimately to mental health problems and hopelessness. Many patients in Pakistan have difficulty maintaining regular treatment schedules, further contributing to feelings of hopelessness (11).
Depression is one of the most common psychological problems among patients undergoing dialysis. Studies indicate that approximately 25% to 50% of dialysis patients in Pakistan experience depressive symptoms (12). Hopelessness is also prevalent and negatively affects treatment outcomes (13). Conversely, hopefulness is a strong predictor of adaptation and plays a crucial role in rehabilitation (14). Interventions targeting patients’ attitudes may reduce psychological distress and enhance hope and treatment adherence.
Laughter therapy (LT) is a nonpharmacological intervention that can influence patients’ psychological status. Laughter is a psychophysiological activity that can positively affect emotional and cognitive states, improve attention, and promote mental well-being (15). Laughter therapy is increasingly used as a complementary, low-cost, safe, and effective intervention (16). It may help reduce depression by enhancing social interaction and improving physical health (17). Studies have also shown that laughter may boost immune function, lower blood pressure, and increase hopefulness (18).
Cognitive behavioral therapy (CBT) is considered one of the most effective psychological interventions for patients undergoing dialysis (19). It focuses on modifying dysfunctional thoughts, enhancing coping skills, and promoting a sense of control over life (20). Therapists use cognitive techniques to help patients identify and restructure negative thoughts, thereby facilitating adaptation to their condition (21).
Cognitive behavioral therapy has been shown to reduce depressive symptoms, anxiety, and negative beliefs while improving self-confidence and overall psychological well-being (19). It also helps patients tolerate uncertainty and reduces their fear of social participation (22).

2. Objectives

Given the importance of mental health and hopefulness for the quality of life of patients undergoing dialysis, this study aimed to compare the effects of LT and CBT on mental health and hopefulness in Pakistani dialysis patients.

3. Methods

3.1. Study Setting and Population

This quasi-experimental study was conducted in Pakistan in 2026. Participants were recruited by convenience sampling from among patients undergoing hemodialysis at a teaching hospital in Lahore. The study population comprised all patients with CRF receiving hemodialysis at the selected hospital. After eligibility screening and provision of written informed consent, eligible participants were enrolled and assigned to the LT, CBT, or control group.
Neither random sampling nor randomized allocation was used. Group assignment followed the study procedures and the practical conditions of the clinical setting. Therefore, the study was designed and conducted as a quasi-experimental study. The sample size was estimated for a three-group comparison using a one-way analysis of variance (ANOVA) framework. The calculation assumed a medium-to-large standardized effect size (Cohen’s f = 0.30), a two-sided significance level of 0.05, and 80% statistical power. Based on these assumptions, a minimum of 135 participants (45 per group) was considered adequate. Because the calculation was based on the primary between-group comparison, correlations between repeated measurements were not incorporated into the initial sample size estimate. To allow for possible attrition during follow-up, 145 participants were recruited.

3.2. Inclusion and Exclusion Criteria

Inclusion criteria were having a permanent medical record at the hospital, willingness to participate, ability to read and write in Urdu, no signs of intellectual disability, no concurrent use of medication for psychiatric disorders, no participation in other nonpharmacological psychological interventions, no reported severe stress during the preceding 3 months, no previous participation in similar interventions, and at least 6 months of dialysis treatment. Exclusion criteria were unwillingness to continue the intervention, absence from more than two intervention sessions, development of major physical or psychological conditions during the intervention that could affect study outcomes, and relocation from the study area.

3.3. Data Collection

To allow for possible attrition, 145 patients who met the inclusion criteria were initially recruited by convenience sampling. After the introductory session, all participants provided written informed consent and were enrolled. Participants were assigned to three groups: LT (n = 48), CBT (n = 48), and control (n = 49). During the intervention period, attrition occurred because of withdrawal and loss to follow-up. Three participants in the LT group, three in the CBT group, and four in the control group did not complete the postintervention assessment, leaving 135 participants who completed that assessment. During the 3-month follow-up, further attrition occurred because of death, kidney transplantation, and loss of contact despite telephone follow-up and home visits, resulting in a final follow-up sample of 121 participants. Attrition and missing outcome data were considered when interpreting the findings. The final analysis included participants with complete outcome data across all assessment time points (Figure 1).
CONSORT Flowchart
Figure 1.
CONSORT Flowchart
Data were collected in three stages. At baseline, eligible participants attended a 2-hour introductory session during which the study objectives and interventions were explained. Participants then completed the study questionnaires. The same instruments were administered immediately after the intervention to participants who completed treatment and again after 3 months to evaluate long-term effects.
A demographic questionnaire was used to collect data. The Symptom Checklist-90-Revised (SCL-90-R) was used to assess psychological symptoms (23). It measures nine dimensions: somatization, obsessive-compulsive symptoms, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. In addition to the subscales, the Global Severity Index (GSI) was used as the main outcome indicator. Responses are rated on a 5-point Likert scale from 0 (not at all) to 4 (extremely). The total or mean score is calculated by summing or averaging item responses. Higher scores indicate greater psychological symptom severity and poorer psychological status, whereas lower scores indicate fewer symptoms and better psychological well-being. The possible SCL-90-R score range depends on the number of items and the scoring method. In this study, the standardized GSI scoring procedure was used, in which a reduction in score indicates improved psychological status or decreased symptom severity. The instrument’s validity and reliability have been confirmed in previous studies (24). Cronbach’s alpha in this study was 0.863.
Hope was measured using the Snyder Hope Scale (SHS), based on Snyder’s hope theory (25). The scale is suitable for individuals aged 15 years or older and for populations with mental health conditions. It consists of 12 items rated on a 5-point Likert scale. Total scores range from 12 to 60, with higher scores indicating greater hope. The scale’s validity and reliability have been established in previous studies. Cronbach’s alpha in this study was 0.826.
Both LT and CBT comprised eight structured 1-hour group sessions in a hospital setting, with 8 - 10 participants per group. The first researcher, who held official CBT certification and had received formal training and certification in LT, facilitated both interventions. The intervention content was developed from standardized protocols and reviewed and approved by clinical psychologists. All sessions were conducted under professional supervision to maintain adherence to the intervention structure and consistency of delivery. To support intervention fidelity, each session followed a structured format: review of previous content, introduction of new material, guided practice, and assignment of home exercises. Fidelity was maintained using a session checklist and periodic supervision by clinical experts, although no external audit was conducted.
The LT intervention included deep-breathing exercises, clapping, gratitude activities, simulated laughter exercises (such as silent, loud, and prolonged laughter), light physical activity, and positive-thinking exercises. Content progressed from basic relaxation and engagement techniques to more interactive and sustained laughter practices aimed at improving emotional well-being. The CBT intervention was based on standard CBT principles and included psychoeducation about the A-B-C model, identification of automatic thoughts and core beliefs, cognitive restructuring, cognitive reframing, rational analysis, behavioral activation, and gradual exposure/desensitization techniques. Sessions were structured sequentially to support the progressive development of cognitive and behavioral coping skills.
The LT and CBT interventions were matched in duration, frequency, and therapist contact time to ensure equivalence between the two intervention groups. To ensure fairness, control-group participants were offered condensed versions of both interventions after completion of the postintervention and follow-up assessments.
Outcome assessors and data analysts were blinded to group allocation to reduce bias in assessment and analysis. Because of the nature of the interventions, participants and intervention providers could not be blinded. To minimize contamination, participants in each group attended separate intervention sessions at different times and were instructed not to share intervention content with participants in other groups during the study. Sessions were held in controlled hospital settings to reduce interaction between groups. The control group received routine hospital care and no structured psychological intervention during the study. No additional therapist contact beyond routine assessments was provided to the control group.

3.4. Data Analysis

Data were analyzed using SPSS version 26. Descriptive statistics, including means and standard deviations, were calculated for all study variables. The normality of continuous variables was assessed using the Shapiro-Wilk test. Changes in psychological symptom severity and hopefulness over time and between groups were examined using repeated-measures analysis of variance (RM-ANOVA), with time (baseline, end of therapy, and 3-month follow-up) as the within-subject factor and group (LT, CBT, and control) as the between-subject factor. Mauchly’s test was used to assess sphericity. When this assumption was violated, the Greenhouse-Geisser correction was applied. Significant interactions or main effects were followed by Bonferroni-adjusted post hoc comparisons. Effect sizes were reported as partial eta squared (ηp2), and 95% confidence intervals were calculated where appropriate. Statistical significance was defined as P < 0.05. Outcome data were missing because some participants did not complete the postintervention or 3-month follow-up assessments. Reasons for loss to follow-up included death, kidney transplantation, and loss of contact. Given the pattern and reasons for missingness, the data were not assumed to be missing completely at random. The primary analysis included participants with complete outcome data across all three assessments. The findings should therefore be interpreted cautiously because complete-case analysis may be affected by attrition-related bias.

3.5. Ethical Considerations

This study was not registered in a clinical trial registry because it was designed as a quasi-experimental study rather than a randomized controlled clinical trial. Ethical approval was obtained from the relevant institutional ethics committee, and the study was conducted in accordance with institutional ethical guidelines (UOL/IREB/26/21/03/0032). A letter of permission was also obtained from the University of Lahore to facilitate access to participants. All patients were fully informed about the study objectives, and written informed consent was obtained before participation. Participants were assured that their information would remain confidential and that they could withdraw at any time without consequences.

4. Results

Table 1 presents the demographic characteristics of participants who completed the intervention. The mean ages in the LT, CBT, and control groups were 48.11 ± 13.56, 49.00 ± 13.14, and 48.30 ± 13.38 years, respectively. The prevalence of coexisting hypertension and diabetes was 71.1%, 71.1%, and 80% in the LT, CBT, and control groups, respectively. Chi-square tests for categorical variables and one-way ANOVA for age indicated no statistically significant baseline differences among the groups (P > 0.05), confirming initial group homogeneity.
Table 1.
Descriptive Statistics for Sample Characteristics a
VariablesLTCBTControlP-Value
Gender0.808
Female19 (42.2)17 (37.8)20 (44.4)
Male26 (57.8)28 (62.2)25 (55.6)
Marital status0.939
Single8 (17.8)5 (11.1)7 (15.6)
Married23 (51.1)27 (60.0)23 (51.1)
Divorced/widowed14 (31.1)13 (28.9)15 (23.3)
Education0.154
≤ high school30 (66.5)34 (75.7)34 (75.7)
BSc degree14 (31.3)9 (19.9)9 (19.9)
≥ MSc degree1 (2.2)2 (4.4)2 (4.4)
Job0.762
Unemployed5 (11.1)9 (20.0)9 (20.0)
Worker6 (13.3)6 (13.3)4 (8.9)
Employee7 (15.6)8 (17.8)10 (22.2)
Retired9 (20.0)3 (6.7)3 (6.7)
Housewife9 (20.0)8 (17.8)7 (15.6)
Other9 (20.0)11 (24.4)12 (26.6)
Frequency of dialysis0.572
Once a week17 (37.8)10 (22.2)14 (31.3)
Twice a week17 (37.8)23 (48.9)21 (46.7)
3 times a week11 (24.4)13 (28.9)10 (22.2)
History of dialysis0.979
6 (mo) up to 2 (y)14 (31.3)13 (28.9)15 (33.3)
2 - 4 (y)14 (31.3)15 (33.3)17 (37.8)
4 - 6 (y)11 (31.1)11 (24.4)8 (17.8)
> 6 (y)6 (13.3)6 (13.3)5 (11.1)
Kidney transplantation0.144
Yes2 (4.4)1 (2.2)3 (6.6)
No43 (95.6)44 (97.8)42 (93.4)
a Values are expressed as No. (%). Abbreviations: LT, laughter therapy; CBT, cognitive behavioral therapy; BSc, Bachelor of Science; MSc, Master of Science.
Table 2 presents descriptive statistics for psychological symptom severity and hopefulness across the three study groups and assessment time points. Although between-group comparisons at individual time points are presented descriptively, the primary evaluation of intervention effects was based on the time × group interaction in the mixed-design RM-ANOVA. Intervention effectiveness was therefore interpreted according to differential changes over time among the groups rather than cross-sectional comparisons at individual postintervention or follow-up assessments.
Table 2.
Descriptive Statistics for Psychological Symptom Severity and Hopefulness Across Study Groups and Time Points a
Variables and PhasesMean ± SDP-Value
Psychological symptom severity
Baseline
LT1.82 ± 0.230.602
CBT1.84 ± 0.21
Control1.89 ± 0.32
End of therapy
LT1.67 ± 0.490.001
CBT1.62 ± 0.48
Control2.13 ± 0.30
Follow-up
LT1.70 ± 0.540.001
CBT1.65 ± 0.47
Control2.13 ± 0.31
Hopefulness
Baseline
LT37.22 ± 2.530.052
CBT39.84 ± 3.13
Control40.06 ± 3.71
End of therapy
LT42.82 ± 4.630.001
CBT42.40 ± 5.36
Control39.82 ± 2.30
Follow-up
LT42.00 ± 5.770.136
CBT42.46 ± 6.01
Control39.03 ± 3.31
a Abbreviations: LT, laughter therapy; CBT, cognitive behavioral therapy; SD, standard deviation.
The mixed-design RM-ANOVA showed a statistically significant time × group interaction for psychological symptom severity (F = 12.714, P < 0.001, ηp2 = 0.300), indicating that changes over time differed significantly among the LT, CBT, and control groups. Both intervention groups showed reductions in symptom severity from baseline to the postintervention assessment, and these improvements were generally maintained at the 3-month follow-up. The control group did not show a similar pattern of improvement (Table 3).
Table 3.
Mixed-Design Repeated-Measures Analysis of Variance for Psychological Symptom Severity a
EffectdfFPηp2
Time218.642< 0.0010.240
Group216.385< 0.0010.219
Time × Group412.714< 0.0010.300
a Time represents the within-subject effect across baseline, post-intervention, and 3-month follow-up. Group represents the between-subject effect among the laughter therapy, cognitive behavioral therapy, and control groups. Time × Group represents differences in changes over time among the three study groups. Abbreviations: df, degrees of freedom; ηp2, partial eta squared.
The mixed-design RM-ANOVA showed a statistically significant time × group interaction for hopefulness (F = 8.563, P < 0.001, ηp2 = 0.224), indicating that changes over time differed significantly among the three groups. Hopefulness increased in both intervention groups from baseline to the postintervention assessment and remained above baseline levels at the 3-month follow-up. The control group showed no comparable improvement over time (Table 4).
Table 4.
Mixed-Design Repeated-Measures Analysis of Variance for Hopefulness a
EffectdfFPηp2
Time215.927< 0.0010.213
Group24.2860.0160.068
Time × Group48.563< 0.0010.224
a Time represents the within-subject effect across baseline, post-intervention, and 3-month follow-up. Group represents the between-subject effect among the laughter therapy, cognitive behavioral therapy, and control groups. Time × Group represents differences in changes over time among the three study groups. Abbreviations: df, degrees of freedom; ηp2, partial eta squared.

5. Discussion

The baseline results regarding psychological distress in these patients were consistent with recent studies showing high levels of psychological distress among patients undergoing hemodialysis, including depression, anxiety, and stress (26, 27).
Baseline hopefulness scores indicated a moderate level of hope. Reduced hopefulness is a common complication among patients undergoing dialysis and can negatively affect quality of life and mental health. Low hopefulness in this population has been confirmed in previous studies (26, 28). As a powerful internal mechanism, hope can motivate individuals to cope with illness. Envisioning better conditions after recovery may also increase hope through a synergistic relationship. Goal setting and the pursuit of goals are common challenges for patients undergoing dialysis; strengthening their abilities may increase hopefulness and help address these challenges (29).
The results showed that LT reduced patients’ psychological distress and increased hopefulness, with benefits persisting at 3 months. Laughter therapy may reduce distress and maintain hope by increasing happiness and encouraging a focus on positive thoughts. As a respiratory exercise, laughter may promote relaxation. It may also help patients cope with depression by improving social interaction and physical health (30). Laughter may improve physical and psychological symptoms without imposing costs on caregivers. In LT, individuals are also encouraged to accept God as a source of strength, which may increase hope and facilitate adaptation to their circumstances. Caregivers and patients’ families may therefore use this approach to improve mood, increase hopefulness, and alleviate physical symptoms and psychological distress (31).
The results indicated that CBT improved psychological symptom severity and hopefulness at the end of therapy and at the 3-month follow-up. Cognitive behavioral therapy is a major intervention for psychological problems and is effective in reducing symptoms and preventing the recurrence of psychological distress (32). The effectiveness of hope therapy, as a component of cognitive interventions, in reducing depression, anxiety, and stress has also been confirmed in previous research (34).
Regarding the long-term effects of these interventions, psychological symptom severity increased slightly between the end of therapy and the 3-month follow-up in both intervention groups but remained below baseline. Hopefulness decreased slightly in the LT group and increased slightly in the CBT group during this interval, but remained above baseline in both groups. Comparison of LT and CBT across the three assessment stages indicated no significant difference in their effects on psychological symptom severity or hopefulness.
Several potential sources of bias should be considered when interpreting these findings. Because of the nature of the behavioral interventions, participants and therapists could not be blinded, potentially introducing performance and expectancy bias. Participants receiving LT or CBT may have expected improvement, which could partly explain the observed reductions in psychological symptom severity. Therapist expectations may also have influenced intervention delivery despite standardized protocols and supervision. Although sessions were held at separate times and interaction among participants was limited, information exchange between groups cannot be excluded. Self-reported outcomes may also have been affected by response bias related to participants’ perceptions and emotional states. The control group received routine care only and may therefore have received less attention than the intervention groups, potentially contributing to the observed between-group differences.
A limitation of this study was the lack of blinding of participants and intervention providers, which was unavoidable because of the nature of the behavioral interventions and may have introduced performance bias. Self-reported questionnaires may also have been affected by response bias related to participants’ emotional and psychological states at assessment. Despite separate sessions and efforts to limit interaction, information exchange between groups cannot be ruled out. Another limitation was the potential difference in attention received by the intervention and control groups, as the latter received routine hospital care without a structured psychological intervention. Attrition, particularly at the 3-month follow-up, was a further limitation. Some participants did not complete all assessments because of death, kidney transplantation, or loss of contact, and the final analysis included only participants with complete outcome data. Missingness may have been related to participants’ clinical conditions, so attrition-related bias cannot be excluded. The absence of a formal assessment of the missingness mechanism and sensitivity analyses further limits the certainty of the findings. Future studies should prospectively plan strategies for handling missing longitudinal data and conduct sensitivity analyses to assess the robustness of their findings.

5.1. Conclusions

In this quasi-experimental study, changes in psychological symptom severity and hopefulness over time differed significantly among the LT, CBT, and control groups. Both intervention groups improved from baseline to the postintervention assessment, and these improvements were generally maintained at the 3-month follow-up. The control group did not show a comparable pattern of improvement. However, the findings should be interpreted cautiously given follow-up attrition, complete-case analysis, and the limitations of the study design. Laughter therapy and CBT may have potential as supportive approaches to improving psychological outcomes and hopefulness among patients undergoing hemodialysis. Further well-designed studies with more rigorous control of attrition and appropriate longitudinal analyses are needed to confirm these findings.

Footnotes

  • AI Use Disclosure:The authors declare that no generative AI tools were used in the creation of this article.

  • Authors' Contribution:M. A. contributed to the conceptualization of the research idea. W. A. and Z. A. conducted the sampling. Sh. S. A. performed the data analysis and interpretation. M. S. prepared the initial draft of the manuscript. Sh. S. A. reviewed and finalized the manuscript. All authors made substantial contributions to the study and reviewed and approved the final version of the manuscript.

  • Conflict of Interests Statement:The authors do not declare any conflicts of interests for this study.

  • Data Availability:The dataset presented in the study is available on request from the corresponding author during submission or after publication.

  • Ethical Approval:UOL/IREB/26/21/03/0032.

  • Funding/Support:No funding was received for this study.

  • Informed Consent:Written informed consent was obtained before participation

References

  • 1.
    Piovani D, Nikolopoulos GK, Bonovas S. Non-Communicable Diseases: The Invisible Epidemic. J Clin Med. 2022;11(19):5939. [PubMed ID: 36233805]. [PubMed Central ID: PMC9572583]. https://doi.org/10.3390/jcm11195939.
  • 2.
    Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11. [PubMed ID: 35529086]. [PubMed Central ID: PMC9073222]. https://doi.org/10.1016/j.kisu.2021.11.003.
  • 3.
    Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, et al. Chronic kidney disease. Nat Rev Dis Primers. 2025 Jan 30;11(1):8. Erratum in: Nat Rev Dis Primers. 2025;11(1). 8. [PubMed ID: 39885176]. https://doi.org/10.1038/s41572-024-00589-9.
  • 4.
    Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990 - 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. [PubMed ID: 32061315]. [PubMed Central ID: PMC7049905]. https://doi.org/10.1016/S0140-6736(20)30045-3.
  • 5.
    Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. [PubMed ID: 38490803]. https://doi.org/10.1016/j.kint.2023.10.018.
  • 6.
    Khan A, Cheema MF, Fatima R, Cheema SS, Butt Z, Gillani S, et al. Prevalence of Chronic Kidney Disease in a High-Risk Population in Urban Lahore, Pakistan: A Cross-sectional Study. Cureus. 2024;16(6):e63296. [PubMed ID: 39077231]. [PubMed Central ID: PMC11284504]. https://doi.org/10.7759/cureus.63296.
  • 7.
    Johansen KL, Gilbertson DT, Li S, Li S, Liu J, Roetker NS, et al. US Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2024;83(4 Suppl 1):A8-A13. [PubMed ID: 38519262]. https://doi.org/10.1053/j.ajkd.2024.01.001.
  • 8.
    Malik S, Allen RJ, Vachharajani TJ, Kluger B, Ahmad I, Saeed F. Dialysis Decision Making, Dialysis Experiences, and Illness Perceptions: A Qualitative Study of Pakistani Patients Receiving Maintenance Hemodialysis. Kidney Med. 2022;4(11). 100550. [PubMed ID: 36353650]. [PubMed Central ID: PMC9637991]. https://doi.org/10.1016/j.xkme.2022.100550.
  • 9.
    Crews DC, Bello AK, Saadi G, Li PKT, Garcia-Garcia G, Andreoli S, et al. Burden, access, and disparities in kidney disease. Kidney Int. 2019;95(2):242-248. [PubMed ID: 30665560]. https://doi.org/10.1016/j.kint.2018.11.007.
  • 10.
    Malhotra K, Fangue‐Nelon J, Singh G. Mental health disorders in end-stage kidney disease: a narrative review of clinical considerations for integrated management. Hemodial Int. 2026;30(4):679-688. [PubMed ID: 42302893]. [PubMed Central ID: PMC13638480]. https://doi.org/10.1111/hdi.70102.
  • 11.
    Adejumo OA, Edeki IR, Sunday Oyedepo D, Falade J, Yisau OE, Ige OO, et al. Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis. J Nephrol. 2024;37(9):2455-2472. [PubMed ID: 38954184]. https://doi.org/10.1007/s40620-024-01998-5.
  • 12.
    Nagy E, Tharwat S, Elsayed AM, Shabaka SAEG, Nassar MK. Anxiety and depression in maintenance hemodialysis patients: prevalence and their effects on health-related quality of life. Int Urol Nephrol. 2023;55(11):2905-2914. [PubMed ID: 37009953]. [PubMed Central ID: PMC10560136]. https://doi.org/10.1007/s11255-023-03556-7.
  • 13.
    Nablawi RA, Alghamdi LS, Alshaikh AE, Alagha AM, Alharbi NT, Ali AH, et al. Quality of life and depression among chronic kidney disease patients: a tertiary care center cross-sectional study. Front. Nephrol. 2025;5. 1600296. [PubMed ID: 41112416]. [PubMed Central ID: PMC12527898]. https://doi.org/10.3389/fneph.2025.1600296.
  • 14.
    Chan K, Wong FKY, Lee PH. A Brief Hope Intervention to Increase Hope Level and Improve Well-Being in Rehabilitating Cancer Patients: A Feasibility Test. SAGE Open Nurs. 2019;5. 2377960819844380. [PubMed ID: 33415238]. [PubMed Central ID: PMC7774404]. https://doi.org/10.1177/2377960819844381.
  • 15.
    Sarink FSM, García-Montes JM. Humor interventions in psychotherapy and their effect on levels of depression and anxiety in adult clients, a systematic review. Front Psychiatry. 2023;13. 1049476. [PubMed ID: 36683998]. [PubMed Central ID: PMC9845902]. https://doi.org/10.3389/fpsyt.2022.1049476.
  • 16.
    Liu CY, Liu TH, Huang CW, Lai CC, Lin CH, Su KP. Effects of laughter therapy on depression and anxiety: A dose-response meta-analysis with trial sequential analysis. Journal of Psychiatric Research. 2026.199;50 - 61. doi.org/10.1016/j. jpsychires. 2026;199:50-61. [PubMed ID: 42019364]. https://doi.org/10.1016/j.jpsychires.2026.04.006.
  • 17.
    Porras-Jiménez, Ym, Pancorbo-Hidalgo, P.l, López-Medina, I.m. et al. The Role of Laughter Therapy in Adults: Life Satisfaction and Anxiety Control. A Systematic Review with Meta-Analysis. J Happiness Stud. 2025;26,(6). 99. https://doi.org/10.1007/s10902-025-00934-z.
  • 18.
    Yamakoshi T, Sakamoto R, Fukuda T, Kanatome A, Koyama A, Ano Y. Effects of laughter on focus and stress in middle-aged adults: a single-blind, randomized controlled trial. BMC Complement Med Ther. 2025;25(1). 123. [PubMed ID: 40170014]. [PubMed Central ID: PMC11959982]. https://doi.org/10.1186/s12906-025-04863-5.
  • 19.
    Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults with Depression: A Network Meta-analysis. JAMA Psychiatry. 2019;76(7):700. [PubMed ID: 30994877]. [PubMed Central ID: PMC6583673]. https://doi.org/10.1001/jamapsychiatry.2019.0268.
  • 20.
    Werson AD, Meiser-Stedman R, Laidlaw K. A meta-analysis of CBT efficacy for depression comparing adults and older adults. J Affect Disord. 2022;319:189-201. [PubMed ID: 36113691]. https://doi.org/10.1016/j.jad.2022.09.020.
  • 21.
    Bhattacharya S, Goicoechea C, Heshmati S, Carpenter JK, Hofmann SG. Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature. Curr Psychiatry Rep. 2023;25(1):19-30. [PubMed ID: 36534317]. [PubMed Central ID: PMC9834105]. https://doi.org/10.1007/s11920-022-01402-8.
  • 22.
    Cuijpers P, Harrer M, Miguel C, Ciharova M, Papola D, Basic D, et al. Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. JAMA Psychiatry. 2025;82(6):563. [PubMed ID: 40238104]. [PubMed Central ID: PMC12004241]. https://doi.org/10.1001/jamapsychiatry.2025.0482.
  • 23.
    Derogatis LR. SCL-90-R: symptom checklist-90-R: administration, scoring & procedures manual. National Computer Systems; 1994.
  • 24.
    Shah SM, Jahangir M, Xu W, Yuan Y. Reliability and validity of the Urdu version of Psychosomatic Symptoms Scale in Pakistani patients. Front Psychol. 2022;13. 861859. [PubMed ID: 35478754]. [PubMed Central ID: PMC9037750]. https://doi.org/10.3389/fpsyg.2022.861859.
  • 25.
    Snyder CR, Harris C, Anderson JR, Holleran SA, Irving LM, Sigmon ST, et al. The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol. 1991;60(4):570-585. [PubMed ID: 2037968]. https://doi.org/10.1037//0022-3514.60.4.570.
  • 26.
    Elezi B, Abazaj E, Zappacosta B, Hoxha M. Anxiety and depression in geriatric hemodialysis patients: factors that influence the border of diseases. Front. Psychol. 2023;14. 1281878. [PubMed ID: 38078242]. [PubMed Central ID: PMC10704351]. https://doi.org/10.3389/fpsyg.2023.1281878.
  • 27.
    Ye W, Wang L, Wang Y, Wang C, Zeng J. Depression and anxiety symptoms among patients receiving maintenance hemodialysis: a single center cross-sectional study. BMC Nephrol. 2022;23(1). 417. [PubMed ID: 36585621]. [PubMed Central ID: PMC9804950]. https://doi.org/10.1186/s12882-022-03051-8.
  • 28.
    Alshraifeen A, Al-Rawashdeh S, Herth K, Alnuaimi K, Alzoubi F, Khraim F, et al. The association between hope and quality of life in haemodialysis patients. Br J Nurs. 2020;29(21):1260-1265. [PubMed ID: 33242282]. https://doi.org/10.12968/bjon.2020.29.21.1260.
  • 29.
    Shek Nam Ng M, Kwok Wei So W, Chow Choi K, Chen J, Sze Ho Wong S, Hui YH, et al. Hope, quality of life, and psychological distress in patients on peritoneal dialysis: A cross-sectional study. J Health Psychol. 2023;28(13):1238-1249. [PubMed ID: 37246408]. https://doi.org/10.1177/13591053231176262.
  • 30.
    Bennett PN, Hussein WF, Reiterman M, Yu J, Schiller B. The effects of laughter therapy on depression symptoms in patients undergoing center hemodialysis: A pragmatic randomized controlled trial. Hemodial Int. 2020;24(4):541-549. [PubMed ID: 32844575]. https://doi.org/10.1111/hdi.12870.
  • 31.
    Sobalvarro JV, Pereira GA, Dominicci AP, Santos-Junior GA, Silva JD, Bavaresco M, et al. Effectiveness of laughter therapy on anxiety and depression in hospitalized patients: a systematic review and meta-analysis. J Hosp Pharm Health Serv. 2023;14(2):906. doi.org/10. 30968/rbfhss. 2023;14(2):906. https://doi.org/10.30968/rbfhss.2023.142.0906.
  • 32.
    Barello S, Anderson G, Acampora M, Bosio C, Guida E, Irace V, et al. The effect of psychosocial interventions on depression, anxiety, and quality of life in hemodialysis patients: a systematic review and a meta-analysis. Int Urol Nephrol. 2023;55(4):897-912. [PubMed ID: 36180655]. [PubMed Central ID: PMC10030538]. https://doi.org/10.1007/s11255-022-03374-3.
  • 33.
    Shahgholian N, Rahimipour M, Yazdani M. Effect of hope therapy on depression, anxiety, and stress among the patients undergoing hemodialysis. Iran J Nurs Midwifery Res. 2015;20(6):694. [PubMed ID: 26793255]. [PubMed Central ID: PMC4700689]. https://doi.org/10.4103/1735-9066.170007.
  • 34.
    Bayan NH, Farahani MJ, Sedaghat N, Mehrabi S, Ramezani F. The Effect of Hope Therapy on the Management of Hemodialysis Outcomes: A Review Article. Cureus. 2024;16(2):e54104. [PubMed ID: 38487128]. [PubMed Central ID: PMC10938270]. https://doi.org/10.7759/cureus.54104.

Copyright

Copyright © 2026, Azam et al. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

9
Oct
2023
Evaluation of the Effect of Group Hope Therapy on Reducing Anxiety and Adherence to Treatment in Hemodialysis Patients

Evaluation of the Effect of Group Hope Therapy on Reducing Anxiety and Adherence to Treatment in Hemodialysis Patients

Zahra Ahmadifajr,
Saeid Foroghi,
Tahere Toulabi,
Mahamad Almasian

Ahmadifajr Z, Foroghi S, Toulabi T, Almasian M. Evaluation of the Effect of Group Hope Therapy on Reducing Anxiety and Adherence to Treatment in Hemodialysis Patients. J Health Rep Technol. 2023;9(4):e140314. doi: https://doi.org/10.5812/jhrt-140314

10
Jan
2015
Effect of Psycho Education on Depression and Anxiety Symptoms in Patients on Hemodialysis

Effect of Psycho Education on Depression and Anxiety Symptoms in Patients on Hemodialysis

Arefeh Beygom Shafaat,
Fatemeh Espahbodi,
Hamzeh Hosseini,
Mohamad Mehdi Mirzade

Shafaat AB, Espahbodi F, Hosseini H, Mirzade MM. Effect of Psycho Education on Depression and Anxiety Symptoms in Patients on Hemodialysis. Iran J Psychiatry Behav Sci. 2015;9(1):-. doi: https://doi.org/10.17795/ijpbs227

25
Aug
2015
A survey of the quality of life in patients undergoing hemodialysis and its association with depression, anxiety and stress

A survey of the quality of life in patients undergoing hemodialysis and its association with depression, anxiety and stress

Vida Shafipour,
Fatemeh Alhani,
Anoshirvan Kazemnejad

Shafipour V, Alhani F, Kazemnejad A. A survey of the quality of life in patients undergoing hemodialysis and its association with depression, anxiety and stress. J Nurs Midwifery Sci. 2015;2(2):e141298. doi:

5
Nov
2024
The Effect of Fordyce Happiness Training on Life Expectancy and Quality of Life in Hemodialysis Patients: An Intervention Study in Yazd, Iran

The Effect of Fordyce Happiness Training on Life Expectancy and Quality of Life in Hemodialysis Patients: An Intervention Study in Yazd, Iran

Bahare Fallah,
Najmeh Baghian,
Akram Mehrabbeik,
Mehdi Karimi Zarchi,
Hossin Nazmiah,
Majid Hajimaghsoudi
,et al.

Fallah B, Baghian N, Mehrabbeik A, Karimi Zarchi M, Nazmiah H, et al. The Effect of Fordyce Happiness Training on Life Expectancy and Quality of Life in Hemodialysis Patients: An Intervention Study in Yazd, Iran. Iran J Psychiatry Behav Sci. 2024;18(4):e127421. doi: https://doi.org/10.5812/ijpbs-127421

16
Aug
2020
The Effect of Positive Thinking Training on Different Dimensions of Quality of Life of Hemodialysis Patients: A Randomized Controlled Clinical Trial

The Effect of Positive Thinking Training on Different Dimensions of Quality of Life of Hemodialysis Patients: A Randomized Controlled Clinical Trial

Mahmoudreza Peyravi,
Mehdi Amirkhani,
Faeze Abadi,
Ali Abbasijahromi,
Shima Sheidaie,
Amene Modreki

Peyravi M, Amirkhani M, Abadi F, Abbasijahromi A, Sheidaie S, et al. The Effect of Positive Thinking Training on Different Dimensions of Quality of Life of Hemodialysis Patients: A Randomized Controlled Clinical Trial. Nephro-Urol Mon. 2020;12(3):e105052. doi: https://doi.org/10.5812/numonthly.105052

More by these authors

Muhammad AzamPubMedScholar
Muhammad SabirPubMedScholar
Waseem AbbasPubMedScholar
Zobia AkramPubMedScholar
Shima Sadat AghahosseiniPubMedScholar
Share
Cited by
Metrics